title: Clozapine for medication-related pathological gambling in Parkinson disease.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Rotondo
authors.forename: Domenico
authors.initials: D
authors.lastname: Bosco
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Plastino
authors.forename: Arturo
authors.initials: A
authors.lastname: Consoli
authors.forename: Francesca
authors.initials: F
authors.lastname: Bosco
mesh_terms: D000328:Adult; D000978:Antiparkinson Agents / Q000009:adverse effects*; D052160:Benzothiazoles / Q000009:adverse effects; D000077465:Cabergoline; D003024:Clozapine / Q000627:therapeutic use*; D004873:Ergolines / Q000009:adverse effects; D005260:Female; D005715:Gambling / Q000139:chemically induced* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D000077487:Pramipexole; D012642:Selegiline / Q000009:adverse effects; D012702:Serotonin Antagonists / Q000627:therapeutic use
chemical_list: D000978:Antiparkinson Agents; D052160:Benzothiazoles; D004873:Ergolines; D012702:Serotonin Antagonists; D012642:Selegiline; D000077487:Pramipexole; D003024:Clozapine; D000077465:Cabergoline